Pharmacokinetics of Indinavir Combined with Low-Dose Ritonavir in Human Immunodeficiency Virus Type 1-Infected Children
2004 ◽
Vol 48
(5)
◽
pp. 1904-1907
◽
Keyword(s):
Low Dose
◽
ABSTRACT So far, no pediatric doses for indinavir combined with ritonavir have been defined. This study evaluated the pharmacokinetics of 400 mg of indinavir/m2 combined with 125 mg of ritonavir/m2 every 12 h (q12h) in 14 human immunodeficiency virus type 1-infected children. The area under the concentration-time curve from 0 to 24 h and the minimum concentration of drug in serum for indinavir were similar to those for 800 mg of indinavir-100 mg of ritonavir q12h in adults, while the maximum concentration of drug in serum was slightly decreased, with geometric mean ratios (90% confidence intervals in parentheses) of 1.1 (0.87 to 1.3), 0.96 (0.60 to 1.5), and 0.80 (0.68 to 0.94), respectively.
2003 ◽
Vol 47
(1)
◽
pp. 118-123
◽
2001 ◽
Vol 45
(3)
◽
pp. 701-705
◽
2007 ◽
Vol 15
(2)
◽
pp. 253-259
◽
2002 ◽
Vol 46
(12)
◽
pp. 3877-3882
◽
2004 ◽
Vol 24
(5)
◽
pp. 592-599
◽
1996 ◽
Vol 40
(3)
◽
pp. 767-771
◽
2005 ◽
Vol 49
(11)
◽
pp. 4721-4732
◽
1999 ◽
Vol 179
(4)
◽
pp. 849-858
◽
2007 ◽
Vol 51
(6)
◽
pp. 2208-2210
◽